Cell therapy weekly: FDA issues strong warning, diabetes gene therapy shows promise in mice, the Cell and Gene Therapy Catapult unveils new project and Takeda eyes an acquisition
Content matching 'The week in cell therapy'
Cell therapy weekly: Novo Nordisk continues to investigate stem cell therapies for chronic diseases and Kite expands manufacturing capability
Cell therapy weekly: Kymriah could be available in Japan and stem cells show benefits against multiple sclerosis
[AAO 2018 Special] Cell therapy weekly: Injury from unapproved cell therapies are more prevalent than reported